{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:05Z","timestamp":1786985765437,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010232","name":"NIDA","doi-asserted-by":"publisher","award":["UH2\/UH3 DA041115"],"award-info":[{"award-number":["UH2\/UH3 DA041115"]}],"id":[{"id":"10.13039\/501100010232","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R01","award":["R01 DA035552"],"award-info":[{"award-number":["R01 DA035552"]}]},{"name":"R01","award":["R01 DA032910"],"award-info":[{"award-number":["R01 DA032910"]}]},{"name":"R01","award":["R01 DA013930"],"award-info":[{"award-number":["R01 DA013930"]}]},{"name":"R01","award":["R01 DA025100"],"award-info":[{"award-number":["R01 DA025100"]}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CHE-1111761"],"award-info":[{"award-number":["CHE-1111761"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cbi.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T22:48:34Z","timestamp":1533336514000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine"],"prefix":"10.1016","volume":"293","author":[{"given":"Kyungbo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhuang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cbi.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)21180-6","article-title":"Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases","volume":"279","author":"Kamendulis","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.cbi.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02791072.1994.10472440","article-title":"Injection drug users in the Midwest: an epidemiologic comparison of drug use patterns in four Ohio cities","volume":"26","author":"Siegal","year":"1994","journal-title":"J. Psychoact. Drugs"},{"issue":"5","key":"10.1016\/j.cbi.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2105\/AJPH.78.5.567","article-title":"Cocaine and heroin dependence compared in poly-drug abusers","volume":"78","author":"Hasin","year":"1988","journal-title":"Am. J. Publ. Health"},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00952999709001685","article-title":"Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment","volume":"23","author":"Grella","year":"1997","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"12","key":"10.1016\/j.cbi.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3109\/10826089809059334","article-title":"Temporal patterns of heroin and cocaine use among methadone patients","volume":"33","author":"Magura","year":"1998","journal-title":"Subst. Use Misuse"},{"issue":"5","key":"10.1016\/j.cbi.2018.08.002_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0740-5472(94)90099-X","article-title":"Illicit use of methadone among i.v. drug users in Montreal","volume":"11","author":"Lauzon","year":"1994","journal-title":"J. Subst. Abuse Treat."},{"issue":"4","key":"10.1016\/j.cbi.2018.08.002_bib7","first-page":"395","article-title":"Characteristics of drug abusers that discriminate needle-sharers","volume":"102","author":"Dolan","year":"1987","journal-title":"Publ. Health Rep."},{"issue":"4","key":"10.1016\/j.cbi.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s002130050415","article-title":"Self-administration of cocaine and heroin combinations by rhesus monkeys responding under a progressive-ratio schedule","volume":"133","author":"Rowlett","year":"1997","journal-title":"Psychopharmacology (Berlin)"},{"issue":"2","key":"10.1016\/j.cbi.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/00952999709040946","article-title":"Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice","volume":"23","author":"Perez de los Cobos","year":"1997","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1037\/0893-164X.14.1.69","article-title":"Contingency management for accurate predictions of urinalysis test results and lack of correspondence with self-reported drug use among polydrug abusers","volume":"14","author":"Downey","year":"2000","journal-title":"Psychol. Addict. Behav."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction"},{"issue":"46","key":"10.1016\/j.cbi.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"16656","DOI":"10.1073\/pnas.0507332102","article-title":"Computational redesign of human butyrylcholinesterase for anticocaine medication","volume":"102","author":"Pan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20133","key":"10.1016\/j.cbi.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cbi.2010.01.004","article-title":"Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine","volume":"187","author":"Yang","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"1\u20133","key":"10.1016\/j.cbi.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cbi.2008.04.024","article-title":"An albumin-butyrylcholinesterase for cocaine toxicity and addiction: catalytic and pharmacokinetic properties","volume":"175","author":"Gao","year":"2008","journal-title":"Chem. Biol. Interact."},{"issue":"8","key":"10.1016\/j.cbi.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biopsych.2011.11.014","article-title":"Cocaine hydrolase encoded in viral vector blocks the reinstatement of cocaine seeking in rats for 6 months","volume":"71","author":"Anker","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cbi.2012.08.006","article-title":"Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage","volume":"203","author":"Gao","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.cbi.2018.08.002_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067446","article-title":"Gene transfer of mutant mouse cholinesterase provides high lifetime expression and reduced cocaine responses with no evident toxicity","volume":"8","author":"Geng","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cbi.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","article-title":"A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats","volume":"33","author":"Brimijoin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cbi.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jcph.450","article-title":"Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects","volume":"55","author":"Cohen-Barak","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/JCP.0000000000000347","article-title":"Assessment of pharmacokinetic and pharmacodynamic interactions between albumin-fused mutated butyrylcholinesterase and intravenously administered cocaine in recreational cocaine users","volume":"35","author":"Shram","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cbi.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2016.05.019","article-title":"Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence","volume":"166","author":"Gilgun-Sherki","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cbi.2018.08.002_bib22","article-title":"Clinical potential of an enzyme-based novel therapy for cocaine overdose","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2018.08.002_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1208\/s12248-017-0167-4","article-title":"Effectiveness of a cocaine hydrolase for cocaine toxicity treatment in male and female rats","volume":"20","author":"Zheng","year":"2018","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/03602537508993748","article-title":"The metabolism of morphine and heroin in man","volume":"4","author":"Boerner","year":"1975","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1039\/C3OB42464B","article-title":"Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine","volume":"12","author":"Qiao","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.cbi.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1021\/bi400709v","article-title":"Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin","volume":"52","author":"Qiao","year":"2013","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.cbi.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bph.12305","article-title":"Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats","volume":"170","author":"Gottas","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.109.152462","article-title":"Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo","volume":"331","author":"Andersen","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1369-1600.2010.00298.x","article-title":"Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice","volume":"18","author":"Boix","year":"2013","journal-title":"Addiction Biol."},{"issue":"3","key":"10.1016\/j.cbi.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.113.212035","article-title":"A monoclonal antibody specific for 6-monoacetylmorphine reduces acute heroin effects in mice","volume":"349","author":"Bogen","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jps.2600680111","article-title":"Pharmacokinetics of morphine and its surrogates II: methods of separation of stabilized heroin and its metabolites from hydrolyzing biological fluids and applications to protein binding and red blood cell partition studies","volume":"68","author":"Garrett","year":"1979","journal-title":"J. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.cbi.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/jps.2600691002","article-title":"Pharmacokinetics of morphine and its surrogates IV: pharmacokinetics of heroin and its derived metabolites in dogs","volume":"69","author":"Garrett","year":"1980","journal-title":"J. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.cbi.2018.08.002_bib33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1139\/y83-132","article-title":"Diacetylmorphine (heroin) hydrolases in human blood","volume":"61","author":"Owen","year":"1983","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9673(00)91213-5","article-title":"Kinetics of heroin deacetylation in aqueous alkaline solution and in human serum and whole blood","volume":"110","author":"Nakamura","year":"1975","journal-title":"J. Chromatogr."},{"issue":"2","key":"10.1016\/j.cbi.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0021-9673(01)82267-6","article-title":"Rapid and sensitive gas chromatographic determination of diacetylmorphine and its metabolite monoacetylmorphine in blood using a nitrogen detector","volume":"105","author":"Smith","year":"1975","journal-title":"J. Chromatogr."},{"issue":"8","key":"10.1016\/j.cbi.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1440-1681.1999.03090.x","article-title":"Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine","volume":"26","author":"Salmon","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)32246-9","article-title":"Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase","volume":"215","author":"Lockridge","year":"1980","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"11","key":"10.1016\/j.cbi.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","article-title":"A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats","volume":"33","author":"Brimijoin","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"36","key":"10.1016\/j.cbi.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1021\/ja803646t","article-title":"Most efficient cocaine hydrolase designed by virtual screening of transition states","volume":"130","author":"Zheng","year":"2008","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.cbi.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1073\/pnas.1517713113","article-title":"Long-acting cocaine hydrolase for addiction therapy","volume":"113","author":"Chen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cbi.2018.08.002_bib41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.62.2.220","article-title":"Re-engineering butyrylcholinesterase as a cocaine hydrolase","volume":"62","author":"Sun","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"44","key":"10.1016\/j.cbi.2018.08.002_bib42","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1021\/ja073724k","article-title":"Free energy perturbation (FEP) simulation on the transition states of cocaine hydrolysis catalyzed by human butyrylcholinesterase and its mutants","volume":"129","author":"Pan","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"46","key":"10.1016\/j.cbi.2018.08.002_bib43","doi-asserted-by":"crossref","first-page":"16656","DOI":"10.1073\/pnas.0507332102","article-title":"Computational redesign of human butyrylcholinesterase for anticocaine medication","volume":"102","author":"Pan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"14","key":"10.1016\/j.cbi.2018.08.002_bib44","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1039\/C3OB42464B","article-title":"Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine","volume":"12","author":"Qiao","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"37","key":"10.1016\/j.cbi.2018.08.002_bib45","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1021\/bi400709v","article-title":"Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin","volume":"52","author":"Qiao","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2018.08.002_bib46","doi-asserted-by":"crossref","first-page":"14064","DOI":"10.1021\/jp076742x","article-title":"Effects of pH in rapid-equilibrium enzyme kinetics","volume":"111","author":"Alberty","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.cbi.2018.08.002_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)32246-9","article-title":"Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase","volume":"215","author":"Lockridge","year":"1980","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.cbi.2018.08.002_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2006.pto_233.x","article-title":"Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients","volume":"98","author":"Rook","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.cbi.2018.08.002_bib49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5414\/CPP38486","article-title":"Pharmacodynamics and pharmacokinetics of intravenously, orally and rectally administered diacetylmorphine in opioid dependents, a two-patient pilot study within a heroin-assisted treatment program","volume":"38","author":"Gyr","year":"2000","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.cbi.2018.08.002_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0009-9236(03)00199-1","article-title":"Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts","volume":"74","author":"Girardin","year":"2003","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927971830557X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927971830557X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:50:35Z","timestamp":1757857835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927971830557X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":50,"alternative-id":["S000927971830557X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.08.002","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}